论文信息 - Abstract 2651: Clinical activity and immune correlates from a phase Ib study evaluating atezolizumab (anti-PDL1) in combination with FOLFOX and bevacizumab (anti-VEGF) in metastatic colorectal carcinoma - 字舞流文

Abstract 2651: Clinical activity and immune correlates from a phase Ib study evaluating atezolizumab (anti-PDL1) in combination with FOLFOX and bevacizumab (anti-VEGF) in metastatic colorectal carcinoma

P. Hegde | H. Hurwitz | J. Bendell | M. Pishvaian | S. Jhunjhunwala | H. Hochster | L. Delamarre | J. Powderly | M. Yadav | R. Funke | E. Cha | S. Eckhardt | Janet E. Murphy | J. Wallin | C. Lieu | D. Waterkamp | Xian He | G. Hernandez | V. Lévêque